Marshall Islands vs Saudi Arabia: Tuberculosis treatment success rate by type
Marshall Islands
92
in 2023
Saudi Arabia
92
in 2023
Marshall Islands rank
30th
Saudi Arabia rank
30th
Tuberculosis treatment success rate by type over time
- Marshall Islands
- Saudi Arabia
How they compare
Marshall Islands currently reports 92 against 92 in Saudi Arabia, a difference of 0.
The two have swapped places 7 times across 26 shared years of data; in 1998 it was Marshall Islands ahead.
Marshall Islands ranks 30th and Saudi Arabia ranks 30th of 194 countries.
Across the 4 decades both report, Marshall Islands averaged higher in 3 and Saudi Arabia in 1.
Head to head by decade
| Decade | Marshall Islands | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 82.5 | 67.5 | 15 | Marshall Islands |
| 2000s | 83.5 | 71.5 | 12 | Marshall Islands |
| 2010s | 79.4 | 72.1 | 7.3 | Marshall Islands |
| 2020s | 87.75 | 90.5 | 2.75 | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Marshall Islands or Saudi Arabia?
- Marshall Islands, at 92 against 92 in Saudi Arabia as of 2023.
- What is the difference in tuberculosis treatment success rate by type between Marshall Islands and Saudi Arabia?
- 0, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Saudi Arabia?
- 26 years are reported by both, from 1998 to 2023.
- How do Marshall Islands and Saudi Arabia rank globally for tuberculosis treatment success rate by type?
- Marshall Islands ranks 30th and Saudi Arabia ranks 30th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.